Corvus Pharmaceuticals Inc (CRVS) — Cash Flow Quality Index

Latest as of March 2025: -0.54x

Corvus Pharmaceuticals Inc (CRVS) has a Cash Flow Quality Index of -0.54x as of March 2025. Operating cash flow of $-8.26 Million is below net income of $15.19 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore CRVS long-term investments to assets to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

-0.54x
Operating CF / Net Income

Operating Cash Flow

$-8.26 Million
USD

Net Income

$15.19 Million
USD

Data as of

Mar 2025
Most recent filing

Annual Cash Flow Quality Index for Corvus Pharmaceuticals Inc (None–None)

Year-by-year earnings quality comparison for Corvus Pharmaceuticals Inc. For live market cap and the full company financial profile, see CRVS stock market capitalisation.

Year Quality Index Operating CF (USD) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.